Bloom Energy Corp

Held by 2 specialist biotech funds

Share on X

Fund Holdings

Driehaus Capital Eventide Asset Management

AI Signal

AI analyst context — unlock full analysis

Position Trend

Feb 13, 2026

$11.9M

1 fund

Feb 17, 2026

$44.8M

1 fund

+276% total institutional value over 2 quarters

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 515,481Value: $44.8M

**Signal Note: Driehaus Capital Initiates $44.8M Position in Bloom Energy (BE)** This is a notable mismatch: Bloom Energy manufactures solid oxide fuel cells for distributed power generation—a clean energy hardware company, not a biotech. Driehaus's biotech-focused mandate makes this acquisition atypical for the fund, suggesting either portfolio diversification into adjacent clean tech or a strategic bet on BE's hydrogen economy positioning ahead of potential policy tailwinds or infrastructure spending catalysts. The $44.8M position size represents material conviction, though absent near-term clinical/commercial biotech catalysts, this warrants clarification on whether this reflects a tactical energy bet or fund strategy shift.

Eventide Asset ManagementNEW

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

AXON2 funds NVDA2 funds VEEV2 funds VCYT2 funds LBRT2 funds RMBS2 funds UNP2 funds LITE

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief:

# Signal Note: Eventide AM Initiates $11.9M Position in Bloom Energy Eventide's new stake in Bloom Energy (fuel cell power systems) likely reflects conviction in hydrogen economy tailwinds and decarbonization infrastructure demand, aligning with the firm's clean energy and ESG mandate. The $11.9M position sizing suggests a modest allocation, potentially opportunistic entry ahead of anticipated hydrogen adoption in industrial/grid applications or near-term contract wins. No near-term binary catalysts are evident; upside hinges on 2024-2025 customer deployments and gross margin expansion as production scales.